Renal neoplasms with TSC/mTOR pathway mutations

From Libre Pathology
Jump to navigation Jump to search

Renal neoplasms with TSC/mTOR pathway mutations is a diverse group of kidney tumours.[1]

Kidney tumours with TSC/mTOR mutations:

Mnemonic: REEL.

See also

References

  1. Kapur P, Brugarolas J, Trpkov K (August 2023). "Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting". Cancers (Basel) 15 (16). doi:10.3390/cancers15164043. PMC 10452688. PMID 37627070. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452688/.
  2. Shah RB, Mehra R (March 2024). "Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up". Adv Anat Pathol 31 (2): 105–117. doi:10.1097/PAP.0000000000000419. PMID 37899532.
  3. 3.0 3.1 3.2 Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O (January 2022). "TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background". Biomedicines 10 (2). doi:10.3390/biomedicines10020322. PMC 8869370. PMID 35203531. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869370/.